Susquehanna International Group’s Emergent Biosolutions EBS Stock Holding History

Susquehanna International Group’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.32M	Buy	159,300 +11,000	+7%	+$114K	﹤0.01%	7189
2025 Q4	$1.83M	Sell	148,300 -6,500	-4%	-$69.6K	﹤0.01%	5832
2025 Q3	$1.37M	Buy	154,800 +104,500	+208%	+$813K	﹤0.01%	6609
2025 Q2	$321K	Buy	50,300 +14,400	+40%	+$82.4K	﹤0.01%	10187
2025 Q1	$174K	Sell	35,900 -132,900	-79%	-$1.1M	﹤0.01%	11083
2024 Q4	$1.61M	Sell	168,800 -43,000	-20%	-$395K	﹤0.01%	5782
2024 Q3	$1.77M	Buy	211,800 +86,300	+69%	+$785K	﹤0.01%	5528
2024 Q2	$856K	Buy	125,500 +100,500	+402%	+$432K	﹤0.01%	6948
2024 Q1	$63.3K	Buy	+25,000	New	+$56.4K	﹤0.01%	11460
2023 Q1	–	Sell	-28,500	Closed	-$337K	–	12738
2022 Q4	$337K	Buy	+28,500	New	+$441K	﹤0.01%	8818
2022 Q3	–	Sell	-60,300	Closed	-$1.87M	–	13370
2022 Q2	$1.87M	Buy	60,300 +12,700	+27%	+$434K	﹤0.01%	5052
2022 Q1	$1.95M	Sell	47,600 -4,600	-9%	-$203K	﹤0.01%	5531
2021 Q4	$2.27M	Buy	52,200 +33,500	+179%	+$1.52M	﹤0.01%	5217
2021 Q3	$936K	Sell	18,700 -20,100	-52%	-$1.22M	﹤0.01%	7726
2021 Q2	$2.44M	Buy	38,800 +2,200	+6%	+$141K	﹤0.01%	5466
2021 Q1	$3.4M	Sell	36,600 -40,400	-52%	-$4.14M	﹤0.01%	4687
2020 Q4	$6.9M	Buy	77,000 +28,300	+58%	+$2.6M	﹤0.01%	2960
2020 Q3	$5.03M	Buy	48,700 +10,000	+26%	+$1.08M	﹤0.01%	3035
2020 Q2	$3.06M	Buy	38,700 +25,600	+195%	+$1.91M	﹤0.01%	3768
2020 Q1	$758K	Buy	13,100 +7,200	+122%	+$415K	﹤0.01%	6008
2019 Q4	$318K	Sell	5,900 -100	-2%	-$5.42K	﹤0.01%	7900
2019 Q3	$314K	Buy	+6,000	New	+$280K	﹤0.01%	8201
2019 Q2	–	Sell	-26,500	Closed	-$1.34M	–	10323
2019 Q1	$1.34M	Buy	26,500 +9,000	+51%	+$531K	﹤0.01%	4440
2018 Q4	$1.04M	Sell	17,500 -5,700	-25%	-$367K	﹤0.01%	4594
2018 Q3	$1.53M	Buy	+23,200	New	+$1.35M	﹤0.01%	4443
2018 Q2	–	Sell	-20,200	Closed	-$1.06M	–	9739
2018 Q1	$1.06M	Buy	20,200 +15,600	+339%	+$777K	﹤0.01%	5107
2017 Q4	$214K	Sell	4,600 -61,900	-93%	-$2.61M	﹤0.01%	8161
2017 Q3	$2.69M	Buy	66,500 +14,400	+28%	+$521K	﹤0.01%	3399
2017 Q2	$1.77M	Buy	52,100 +39,500	+313%	+$1.22M	﹤0.01%	4136
2017 Q1	$366K	Sell	12,600 -17,000	-57%	-$517K	﹤0.01%	7037
2016 Q4	$972K	Buy	29,600 +8,300	+39%	+$249K	﹤0.01%	5592
2016 Q3	$672K	Sell	21,300 -22,700	-52%	-$660K	﹤0.01%	5523
2016 Q2	$1.24M	Buy	44,000 +19,600	+80%	+$768K	﹤0.01%	4420
2016 Q1	$887K	Buy	24,400 +14,300	+142%	+$505K	﹤0.01%	5329
2015 Q4	$404K	Sell	10,100 -1,200	-11%	-$41.8K	﹤0.01%	7160
2015 Q3	$322K	Buy	+11,300	New	+$372K	﹤0.01%	7911
2014 Q2	–	Sell	-11,300	Closed	-$286K	–	9810
2014 Q1	$286K	Sell	11,300 -14,100	-56%	-$356K	﹤0.01%	7657
2013 Q4	$584K	Buy	+25,400	New	+$530K	﹤0.01%	6446

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Susquehanna International Group's EBS Position: Q1 2026 in Review

Susquehanna International Group reduced its Emergent Biosolutions (EBS) stake by 87% in Q1 2026, selling an estimated $3.41M and leaving 48,439 shares worth $402K. The position accounts for ﹤0.01% of the portfolio, ranked #10199.

Susquehanna International Group first reported a position in EBS in Q1 2014 and has held it in 35 quarters since. The position peaked at $13.7M in Q3 2020. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

Susquehanna International Group held 48,439 shares of Emergent Biosolutions worth $402K as of Q1 2026.
Susquehanna International Group sold 329,273 Emergent Biosolutions shares in Q1 2026, an estimated $3.41M.
Emergent Biosolutions made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10199 holding.
Susquehanna International Group first reported a position in Emergent Biosolutions in Q1 2014 and has held it in 35 quarters since.
Susquehanna International Group's Emergent Biosolutions position peaked at $13.7M in Q3 2020.
190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.